217 related articles for article (PubMed ID: 1478260)
1. Repeated systemic administration of the mixed inhibitor of enkephalin-degrading enzymes, RB101, does not induce either antinociceptive tolerance or cross-tolerance with morphine.
Noble F; Turcaud S; Fournié-Zaluski MC; Roques BP
Eur J Pharmacol; 1992 Nov; 223(1):83-9. PubMed ID: 1478260
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of the enkephalin-metabolizing enzymes by the first systemically active mixed inhibitor prodrug RB 101 induces potent analgesic responses in mice and rats.
Noble F; Soleilhac JM; Soroca-Lucas E; Turcaud S; Fournie-Zaluski MC; Roques BP
J Pharmacol Exp Ther; 1992 Apr; 261(1):181-90. PubMed ID: 1560364
[TBL] [Abstract][Full Text] [Related]
3. Lack of physical dependence in mice after repeated systemic administration of the mixed inhibitor prodrug of enkephalin-degrading enzymes, RB101.
Noble F; Coric P; Fournié-Zaluski MC; Roques BP
Eur J Pharmacol; 1992 Nov; 223(1):91-6. PubMed ID: 1478261
[TBL] [Abstract][Full Text] [Related]
4. RB101(S), a dual inhibitor of enkephalinases does not induce antinociceptive tolerance, or cross-tolerance with morphine: a c-Fos study at the spinal level.
Le Guen S; Noble F; Fournié-Zaluski MC; Roques BP; Besson JM; Buritova J
Eur J Pharmacol; 2002 Apr; 441(3):141-50. PubMed ID: 12063085
[TBL] [Abstract][Full Text] [Related]
5. Antinociceptive response induced by mixed inhibitors of enkephalin catabolism in peripheral inflammation.
Maldonado R; Valverde O; Turcaud S; Fournié-Zaluski MC; Roques BP
Pain; 1994 Jul; 58(1):77-83. PubMed ID: 7970841
[TBL] [Abstract][Full Text] [Related]
6. Unlike morphine the endogenous enkephalins protected by RB101 are unable to establish a conditioned place preference in mice.
Noble F; Fournié-Zaluski MC; Roques BP
Eur J Pharmacol; 1993 Jan; 230(2):139-49. PubMed ID: 8422896
[TBL] [Abstract][Full Text] [Related]
7. Facilitation of enkephalins catabolism inhibitor-induced antinociception by drugs classically used in pain management.
Nieto MM; Wilson J; Walker J; Benavides J; Fournié-Zaluski MC; Roques BP; Noble F
Neuropharmacology; 2001 Sep; 41(4):496-506. PubMed ID: 11543770
[TBL] [Abstract][Full Text] [Related]
8. Facilitation of enkephalins-induced delta-opioid behavioral responses by chronic amisulpride treatment.
Cordonnier L; Sanchez M; Roques BP; Noble F
Neuroscience; 2005; 135(1):1-10. PubMed ID: 16084652
[TBL] [Abstract][Full Text] [Related]
9. A selective CCKB receptor antagonist potentiates, mu-, but not delta-opioid receptor-mediated antinociception in the formalin test.
Noble F; Blommaert A; Fournié-Zaluski MC; Roques BP
Eur J Pharmacol; 1995 Jan; 273(1-2):145-51. PubMed ID: 7737308
[TBL] [Abstract][Full Text] [Related]
10. Weak tolerance to the antinociceptive effect induced by the association of a peptidase inhibitor and a CCKB receptor antagonist.
Valverde O; Blommaert AG; Fournié-Zaluski MC; Roques BP; Maldonado R
Eur J Pharmacol; 1995 Nov; 286(1):79-93. PubMed ID: 8566154
[TBL] [Abstract][Full Text] [Related]
11. Antinociceptive effects of RB101(S), a complete inhibitor of enkephalin-catabolizing enzymes, are enhanced by (+)-HA966, a functional NMDA receptor antagonist: a c-Fos study in the rat spinal cord.
Buritova J; Le Guen S; Fournié-Zaluski MC; Roques BP; Besson JM
Eur J Pain; 2003; 7(3):241-9. PubMed ID: 12725847
[TBL] [Abstract][Full Text] [Related]
12. Effects of the potent analgesic enkephalin-catabolizing enzyme inhibitors RB101 and kelatorphan on respiration.
Boudinot E; Morin-Surun M; Foutz AS; Fournié-Zaluski M; Roques BP; Denavit-Saubié M
Pain; 2001 Feb; 90(1-2):7-13. PubMed ID: 11166965
[TBL] [Abstract][Full Text] [Related]
13. Cholecystokinin B antagonists strongly potentiate antinociception mediated by endogenous enkephalins.
Valverde O; Maldonado R; Fournie-Zaluski MC; Roques BP
J Pharmacol Exp Ther; 1994 Jul; 270(1):77-88. PubMed ID: 8035345
[TBL] [Abstract][Full Text] [Related]
14. Role of endogenous cholecystokinin in the facilitation of mu-mediated antinociception by delta-opioid agonists.
Noble F; Smadja C; Roques BP
J Pharmacol Exp Ther; 1994 Dec; 271(3):1127-34. PubMed ID: 7996417
[TBL] [Abstract][Full Text] [Related]
15. RB 101, a purported pro drug inhibitor of enkephalin metabolism, is antinociceptive in pregnant mice.
Jayaram A; Singh P; Noreuil T; Fournié-Zaluski MC; Carp HM
Anesth Analg; 1997 Feb; 84(2):355-8. PubMed ID: 9024028
[TBL] [Abstract][Full Text] [Related]
16. Selective antagonism by naltrindole of the antinociceptive effects of the delta opioid agonist cyclic[D-penicillamine2-D-penicillamine5]enkephalin in the rat.
Drower EJ; Stapelfeld A; Rafferty MF; de Costa BR; Rice KC; Hammond DL
J Pharmacol Exp Ther; 1991 Nov; 259(2):725-31. PubMed ID: 1658309
[TBL] [Abstract][Full Text] [Related]
17. Further evidence for the interaction of mu- and delta-opioid receptors in the antinociceptive effects of the dual inhibitor of enkephalin catabolism, RB101(S). A spinal c-Fos protein study in the rat under carrageenin inflammation.
Le Guen S; Catheline G; Fournié-Zaluski MC; Roques BP; Besson JM; Buritova J
Brain Res; 2003 Mar; 967(1-2):106-12. PubMed ID: 12650971
[TBL] [Abstract][Full Text] [Related]
18. Selective blockage of delta opioid receptors prevents the development of morphine tolerance and dependence in mice.
Abdelhamid EE; Sultana M; Portoghese PS; Takemori AE
J Pharmacol Exp Ther; 1991 Jul; 258(1):299-303. PubMed ID: 1649297
[TBL] [Abstract][Full Text] [Related]
19. Antinociceptive effects of RB101, a complete inhibitor of enkephalin-catabolizing enzymes, are enhanced by a cholecystokinin type B receptor antagonist, as revealed by noxiously evoked spinal c-Fos expression in rats.
Honore P; Buritova J; Fournié-Zaluski MC; Roques BP; Besson JM
J Pharmacol Exp Ther; 1997 Apr; 281(1):208-17. PubMed ID: 9103499
[TBL] [Abstract][Full Text] [Related]
20. Physiological control of emotion-related behaviors by endogenous enkephalins involves essentially the delta opioid receptors.
Nieto MM; Guen SL; Kieffer BL; Roques BP; Noble F
Neuroscience; 2005; 135(2):305-13. PubMed ID: 16112476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
